SEC Form 4 · accession 0001493152-26-043174
EXOZYMES INC. · EXOZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fouad Nawaz
Officer — Vice President- Finance
Period of report
Sep 14, 2026
Accepted (ET)
Sep 17, 2026 · 5:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002010788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | holding | — | — | — | 9,488 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.28 | Sep 14, 2026 | A | 45,000 | A | — | Sep 14, 2033 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1The option vests over a three (3) year period in twelve (12) equal quarterly installments of 3,750 shares at the end of each quarter of the calendar year, commencing with the first full calendar quarter following the date of grant. The first installment vests on 12/31/2026 and the final installment vests on 09/30/2029. The option expires on 09/14/2033.